Spirulina
A nutrient-dense algae whose supplement file is a split lipid literature and a product-quality warning.
C
Evidence grade
C-
Worth it
$15-30/month
Typical cost
DoseTrials use 1 to 8 g a day, most at 2 to 4.5 g, over 4 to 12 weeks. Nothing supports the 10 g-plus intakes some protocols use, and the protein arithmetic does not improve at any dose a person will actually take.
BasisThe two best poolings of the lipid trials disagree: the GRADE-assessed 2023 dose-response meta-analysis (20 RCTs, 1,076 participants) finds LDL, total cholesterol, and triglycerides improved (SMD about -0.6), while the 2025 RCT-only pooling (9 trials) finds no significant lipid effect.
Spirulina is dried Arthrospira cyanobacteria, sold as powder and tablets. We grade Spirulina C on evidence and C- for worth-it at about $15-30 per month.
What it does
Spirulina is dried Arthrospira cyanobacteria, sold as powder and tablets. It is genuinely nutrient-dense per gram (roughly 60 percent protein by dry weight, real iron and beta-carotene), but it is eaten in gram servings, and its supplement trial file is small, short, and divided against itself on its flagship claim.
What the research says
Lowers cholesterol and triglycerides
Evidence: emerging. Contested between poolings, stated openly: Rahnama et al. 2023 (Pharmacological Research, 20 RCTs) pools significant improvements; Pinto-Leite et al. 2025 (Nutrients, 9 RCTs) pools none. Trial doses 1 to 8 g a day over 4 to 12 weeks. No cardiovascular outcome has ever been trialled.
Lowers blood pressure
Evidence: emerging. Two poolings agree on direction at small magnitude (systolic about -4.4 to -4.6 mmHg), concentrated in participants with hypertension; dose-response not significant in the larger pooling. An adjunct-scale effect, not a treatment.
Improves blood sugar control in type 2 diabetes
Evidence: emerging. Pooled fasting glucose fell; HbA1c did not. The record grades the endpoint that matters as unproven and says so in the claim's own note.
A protein and vitamin B12 source (the label claim)
Evidence: unsupported. The arithmetic defeats the protein claim (about 60 percent protein by weight, at 3 to 7 gram servings, is 2 to 4 grams of protein), and the B12 claim fails on chemistry: most of spirulina's corrinoids are pseudovitamin B12, inactive in humans (Watanabe). A vegan relying on spirulina for B12 is relying on an analog that does not do the vitamin's job.
The two best poolings of the lipid trials disagree: the GRADE-assessed 2023 dose-response meta-analysis (20 RCTs, 1,076 participants) finds LDL, total cholesterol, and triglycerides improved (SMD about -0.6), while the 2025 RCT-only pooling (9 trials) finds no significant lipid effect. Blood pressure pools small and directionally consistent in mostly hypertensive samples; fasting glucose fell in pooled diabetes trials while HbA1c, the meaningful endpoint, did not move. NIH assesses the evidence as insufficient to recommend spirulina for any condition. A contested flagship claim on small, short trials prices at C.
Is it worth it?
At $15 to $30 a month, the buyer gets a contested lipid claim, a small blood-pressure effect if hypertensive, and a real product-quality risk that testing discipline, not price, controls. As a food it is unobjectionable; as a supplement purchase the file does not carry the cost.
Typical cost
$15-30/month
Common form, not a brand recommendation
Dosage context established
Trials use 1 to 8 g a day, most at 2 to 4.5 g, over 4 to 12 weeks. Nothing supports the 10 g-plus intakes some protocols use, and the protein arithmetic does not improve at any dose a person will actually take.
The worth-it ranking
Spirulina sits outside the worth-it ranking of 38.
Spirulina sits outside that ranking of 38. The leaders below clear an evidence floor of B- before price counts at all, so cheap alone never earns a rank.
- 1AWorth itCreatine evidence A-~$5-10/mo
- 2AWorth itCaffeine evidence B+~$5-10/mo
- 3AWorth itVitamin D evidence B~$5-8/mo
When the evidence moves a grade, this ranking moves with it. Thursday is where you hear it first.
Safety notes
The safety centre of this record is product quality, not the algae itself. Spirulina grows in open ponds and alkaline lakes where other cyanobacteria can co-occur: microcystins (hepatotoxins) have been detected in a share of tested blue-green algae products (Gilroy et al. 2000, some above the interim guidance value applied there), and heavy-metal content varies by source. The practical rule is a class specification: a third-party tested product from a controlled cultivation source, never an untested bulk powder. The BMAA question is carried as a dispute, not a finding: detection of the cyanobacterial toxin in supplements is contested between methods, and this record neither condemns nor clears on it. Vitamin K content makes habitual high intakes a warfarin conversation; phenylalanine content is a PKU label fact; autoimmune caution is theoretical and stated as such.
Changelog
Last updated 2026-11-15
- 2026-11-15|The lipid claim graded as contested between the two best poolings, both printed; the B12 label claim graded unsupported on the pseudovitamin evidence; safety centre set to product quality and microcystin contamination, per the spirulina order ruling.
The week's longevity and biohacking news.
Every story graded against the evidence. Free. Unsubscribe anytime.
The week's longevity and biohacking news. Every story graded against the evidence. Free. Unsubscribe anytime.
Every grade follows a published rubric. Sponsors do not influence findings or grades.